MARKET

AEMD

AEMD

Aethlon Medical
NASDAQ
0.3104
+0.0148
+5.01%
After Hours: 0.3092 -0.0012 -0.39% 18:36 05/26 EDT
OPEN
0.3049
PREV CLOSE
0.2956
HIGH
0.3200
LOW
0.3000
VOLUME
133.43K
TURNOVER
0
52 WEEK HIGH
2.460
52 WEEK LOW
0.2250
MARKET CAP
7.13M
P/E (TTM)
-0.4415
1D
5D
1M
3M
1Y
5Y
BRIEF-Aethlon Medical Receives Ethics Board Approval To Add Second Site To Ongoing Clinical Trial Of Its Hemopurifier
Reuters · 05/22 12:49
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India
PR Newswire · 05/22 12:01
Report of Mpox Cases Rising in Vaccinated People In Chicago, France
Benzinga · 05/12 10:30
World Health Organization Says Mpox Is No Longer A Global Health Emergency
Benzinga · 05/11 14:21
BRIEF-Aethlon Medical Says Nasdaq Informed Co That Request For Extension Of Time To Regain Compliance Was Granted
Reuters · 04/25 17:54
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 04/20 17:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 04/20 17:31
Watching Aethlon Medical; Zacks Small-Cap Research Sets $5.76 Price Valuation
Benzinga · 02/15 18:10
More
About AEMD
Aethlon Medical, Inc. (Aethlon) is a biotechnology company. The Company is focused on developing products to diagnose and treat life and organ-threatening diseases. It is involved in developing the Hemopurifier, a therapeutic blood filtration system indicated for infectious diseases and cancer. The Company operates through two segments: Aethlon and ESI. The Aethlon segment represents its therapeutic business activities. The ESI segment represents its diagnostic business. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seeding the spread of metastasis. The Company is conducting clinical trials in patients with advanced and metastatic head and neck cancer. It is focused on the treatment of solid tumors that are being treated with checkpoint inhibitors. Hemopurifier have been used to treat individuals infected with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and Ebola.

Webull offers kinds of Aethlon Medical, Inc. stock information, including NASDAQ:AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.